Joe Zakrzewski, Angel Investor

Joe Zakrzewski is a Biotech/Pharmaceutical Executive, Board Member, and Investor based in Princeton, New Jersey. He is mostly invested in Biotech and Pharmaceutical companies such as Amarin, OrbiMed, Xcellerex, Reliant Pharmaceuticals, and many more. He is Chairman of the board of Directors at Atsena Therapeutics, a clinical-stage ocular gene therapy company developing novel treatments for inherited forms of blindness. He is also a Board Member and Chairman at Cyteir Therapeutics, a clinical-stage oncology company focused on the development of CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters. He is also an Investor in AN2 Therapeutics, Inc.